ASTEC — Astec Lifesciences Share Price
0.000.00%
Last trade - 00:00- IN₹13.92bn
- IN₹19.43bn
- IN₹3.81bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.94 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | 0.14% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.93 | ||
| Price to Tang. Book | 6.59 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.65 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -21.31% | ||
| Return on Equity | -44.62% | ||
| Operating Margin | -28.83% | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 5,548.72 | 6,765.66 | 6,281.66 | 4,581.81 | 3,813.03 | 7,864 | 9,218 | -6.11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +36.42 | +38.03 | -71.13 | n/a | n/a | n/a | +51.98 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company has also developed capabilities and infrastructure which enables it to undertake contract development and manufacturing services for a diverse range of agrochemicals, catering to the needs of global innovators in the sector. Its products & solutions include agrochemical actives, intermediates and specialty chemicals, and contract development and manufacturing operations. The Company's agrochemical actives include triazole fungicides, herbicides and insecticides. It has a sales mix of both exports and domestic sales. It exports to approximately 17 countries including the United States and countries across Europe, West Asia, South-East Asia and Latin America and Africa. The Company has approximately four manufacturing plants, which are located in Mahad, Maharashtra.
Directors
- N. Godrej CHM
- Anurag Roy CEO (47)
- Saurav Bhala CFO
- Arijit Mukherjee COO
- Tejal Jariwala CCO
- Rakesh Dogra DRC
- Balram Yadav NED
- Vijay Khot IND
- Brahma Vyas IND
- Nandkumar Dhekne NID
- Rishinaradamangalam Govindan NID (65)
- Anjali Gupte NID (50)
- Last Annual
- March 31st, 2025
- Last Interim
- March 31st, 2025
- Incorporated
- January 25th, 1994
- Public Since
- November 25th, 2009
- No. of Employees
- 421
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 19,611,371
- Address
- Godrej One, 3rd Floor, Pirojshanagar,, E, MUMBAI, 400079
- Web
- https://www.astecls.com/
- Phone
- +91 null2225188010
- Contact
- Tejashree Pradhan
- Auditors
- BSR & Co. LLP
Upcoming Events for ASTEC
Q1 2026 Astec Lifesciences Ltd Earnings Release
Astec Lifesciences Ltd Annual Shareholders Meeting
Q2 2026 Astec Lifesciences Ltd Earnings Release
Similar to ASTEC
20 Microns
National Stock Exchange of India
Aarti Industries
National Stock Exchange of India
Aarti Surfactants
National Stock Exchange of India
Abm International
National Stock Exchange of India
Advanced Enzyme Technologies
National Stock Exchange of India
FAQ
What is the Astec Lifesciences share price?
As of Today at 19:23 UTC, shares in Astec Lifesciences are trading at IN₹709.65. This share price information is delayed by 15 minutes.
How has the Astec Lifesciences share price performed this year?
Shares in Astec Lifesciences last closed at IN₹709.65 and the price had moved by -42.94% over the past 365 days. In terms of relative price strength the Astec Lifesciences share price has underperformed the S&P BSE 100 Index by -46.25% over the past year.
What are the analyst and broker recommendations for Astec Lifesciences?
The overall consensus recommendation for Astec Lifesciences is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Astec Lifesciences dividend yield?
Astec Lifesciences does not currently pay a dividend.
Does Astec Lifesciences pay a dividend?
Astec Lifesciences does not currently pay a dividend.
When does Astec Lifesciences next pay dividends?
Astec Lifesciences does not currently pay a dividend.
How do I buy Astec Lifesciences shares?
To buy shares in Astec Lifesciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Astec Lifesciences?
As of the previous close price of IN₹709.65, shares in Astec Lifesciences had a market capitalisation of IN₹13.92bn.
Where are Astec Lifesciences shares listed?
Here are the trading details for Astec Lifesciences:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ASTEC
What kind of share is Astec Lifesciences?
Based on an overall assessment of its quality, value and momentum Astec Lifesciences is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Astec Lifesciences share price forecast for 2025?
The analyst consensus target price for shares in Astec Lifesciences is IN₹1,500.00. That is 111.37% above the last closing price of IN₹709.65.
Analysts covering Astec Lifesciences currently have a consensus Earnings Per Share (EPS) forecast of IN₹40.40 for the next financial year.
Find out moreWhat is the trend in the Astec Lifesciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Astec Lifesciences. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -31.69%.
As of the last closing price of IN₹709.65, shares in Astec Lifesciences were trading -31.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Astec Lifesciences PE Ratio?
The Astec Lifesciences PE ratio based on its reported earnings over the past 12 months is 16.94. The shares last closed at IN₹709.65.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Astec Lifesciences?
Astec Lifesciences' management team is headed by:
- N. Godrej - CHM
- Anurag Roy - CEO
- Saurav Bhala - CFO
- Arijit Mukherjee - COO
- Tejal Jariwala - CCO
- Rakesh Dogra - DRC
- Balram Yadav - NED
- Vijay Khot - IND
- Brahma Vyas - IND
- Nandkumar Dhekne - NID
- Rishinaradamangalam Govindan - NID
- Anjali Gupte - NID